FPH Announces Its Full Year Results; Profit Up by 37%

  • Jun 29, 2020 NZST
  • Team Kalkine
FPH Announces Its Full Year Results; Profit Up by 37%

For the 12 months ended 31st March 2020 Fisher & Paykel Healthcare Corporation Limited (NZX: FPH) reported operating revenue of $1.26 billion, up 18% over last year, or 14% in constant currency. Net profit after tax stood at $287.3 million, up 37% over the previous year, or 30% in constant currency.

The increase in revenue was mainly led by growth in the demand for products to treat COVID-19 patients, increase in the usage of the company’s OptiflowTM nasal high flow therapy and robust hospital hardware sales during the course of the year.


The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. The above article is NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) under discussion. Kalkine does not in any way endorse or recommend individuals, products or services that may be discussed on this site.


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK